Keros Therapeutics Operating Expenses 2011-2026 | KROS

Annual Operating Expenses Keros Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
176 M	214 M	170 M	115 M	76.5 M	46.7 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
214 M	46.7 M	133 M

Quarterly Operating Expenses Keros Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
29.6 M	58 M	59.2 M	-	59 M	50.5 M	48.6 M	-	43.3 M	41.3 M	38.9 M	-	28 M	30.7 M	24.1 M	-	20.2 M	15.6 M	15.8 M	-	11.9 M	10.9 M	10.5 M	-	4.83 M	5.15 M	5.36 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
59.2 M	4.83 M	29.1 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Grifols, S.A. GRFS	1.64 B	$ 7.72	1.85 %	$ 6.83 B	Spain
Amphastar Pharmaceuticals AMPH	216 M	$ 19.68	0.92 %	$ 920 M	USA
Amarin Corporation plc AMRN	171 M	$ 14.5	0.03 %	$ 6.02 B	Irlanda
GlaxoSmithKline plc GSK	16.2 B	$ 52.37	1.02 %	$ 173 B	Britain
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
Ascendis Pharma A/S ASND	338 M	$ 221.59	-0.13 %	$ 5 B	Danmark
Autolus Therapeutics plc AUTL	145 M	$ 1.39	1.46 %	$ 355 M	Britain
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	65.1 M	-	10.36 %	$ 9.8 M	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Heron Therapeutics HRTX	281 M	$ 0.81	3.74 %	$ 135 M	USA
Avenue Therapeutics ATXI	5.21 K	-	-52.27 %	$ 4.45 M	USA
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Benitec Biopharma BNTC	9.83 M	$ 11.05	0.64 %	$ 455 M	USA
Atreca BCEL	98.7 M	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	125 M	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	142 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	120 M	-	-	$ 3.74 B	USA
Immunovant IMVT	438 M	$ 24.1	4.85 %	$ 3.65 B	USA
Bellerophon Therapeutics BLPH	22.4 M	-	-74.18 %	$ 955 K	USA
Incyte Corporation INCY	1.62 B	$ 90.36	-0.47 %	$ 17.6 B	USA
InMed Pharmaceuticals INM	9.78 M	$ 0.74	-9.75 %	$ 1.81 M	Canada
INmune Bio INMB	29.9 M	$ 1.17	-0.43 %	$ 21 M	USA
Checkpoint Therapeutics CKPT	56.2 M	-	-	$ 169 M	USA
Clovis Oncology CLVS	425 M	-	-7.23 %	$ 13 M	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Compugen Ltd. CGEN	40.4 M	$ 2.13	1.91 %	$ 199 M	Israel
Innate Pharma S.A. IPHA	71.7 M	$ 1.35	15.38 %	$ 235 M	France
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	96.2 M	$ 4.43	4.6 %	$ 735 M	Canada
Inventiva S.A. IVA	36.2 M	$ 6.1	5.5 %	$ 138 M	France
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA